111
Participants
Start Date
March 7, 2017
Primary Completion Date
December 15, 2018
Study Completion Date
December 15, 2018
Fampridine
The non-interventional design allows the observation of patients in a broad range of settings reflecting routine clinical practice. All decisions on therapeutic or diagnostic procedures, treatments and management of the disease will be at the full discretion of the treating physician without interference by a sponsor or study protocol. All treatment decisions will follow the real-life treatment behavior.
Αiginitio hospital, Athens
Genesis Pharma CNS & Specialty
INDUSTRY